Colton, “Implantable Biohybrid Artificial Organs”, 4 Cell Transplant 415-36 (1995). |
Spector et al., “The Local Tissue Response to Biomaterials”, 5 Crit. Rev. Biocompat. 269-95 (1989). |
Freeman et al., “Study of the Mass Transport Resistance of Glucose Across Rat Capsular Membranes”, 110 Mater, Res. Soc. Symp. Proc. 773-78 (1989). |
Brauker et al., “Neovascularization of Synthetic Membranes Directed by Membrane Microarchitecture”, 29 J. Biomed. Mat. Res. 1517-24 (1995). |
Padera et al., “Time Course of Membrane Microarchitecture-driven Neovascularization”, 17 Biomaterials 277-84 (1996). |
DeFife et al., “Cytoskeletal and Adhesive Structural Polarizations Accompany IL-13-induced Human Macrophage Fusion”, 47 The Journal of Histochemical Society, Inc. 65-74 (1999). |
DeFife et al., “Disruption of Filamentous Actin Inhibits Human Macrophage Fusion”, 13 FASEB Journal 823-832 (1999). |
Nelson et al., “Microfabrication of Porous Polyimide Membranes”, 183rd meeting of The Electrochemical Society, Inc. (1993). |
Beirne et al., “Microfabricated Polyimide Membrane Test Structures”, publication title and date unknown. |
Lukkassen, “An Investigation into the Causes of Pyrogenic Reactions in Haemodialysis and Haemodiafiltration Patients”, Thesis submitted to Univ. of Oslo (1997). |
Fennrich, “Detection of Endotoxins and Other Pyrogens Using Human Whole Blood”, Development of Biological Standards (1999). |
Hartung et al., “Detection of Pyrogens Using Humans Whole Blood”, 9 In Vito Toxicology 353-359 (1996). |
Poole et al., “Detection of Pyrogen by Cytokine Release”, The Lancet 130 (Jan. 16, 1988). |
Subkowski et al., “Monoclonal Antibodies Against Human Endothelin-Converting Enzyme-1”, 19 Journal of Immunoassay 75-93 (1998). |
Finch-Arietta et al., “Cytokine Production in Whole Blood ex vivo”, 34 Agents and Actions 49-52 (1991). |
Desch et al., “Production of Human Tumor Necrosis Factor from Whole Blood Ex Vivo”, 8 Lymphokine Research 141-146 (1989). |
Taktak, et al., “Assay of Pyrogens by Interleukin-6 Release from Monocytic Cell Lines”, 43 J. Pharm. Pharamacol. 578-582 (1991). |